Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald C Goff

Showing results (71-80 of 207) with videos related to

Pageof 21
Sort By:
Schizophrenia Research|September 1, 2023
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)Donald C Goff, Michele Santacatterina, Gillian Capichioni, et al.
Schizophrenia Bulletin|August 22, 2019
Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic TreatmentEsther M Blessing, Vishnu P Murty, Botao Zeng, et al.
The American Journal of Psychiatry|April 2, 2004
Anterior cingulate cortex activation during cognitive interference in schizophreniaStephan Heckers, Anthony P Weiss, Thilo Deckersbach, et al.
Schizophrenia Research|July 5, 2011
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophreniaJennifer D Gottlieb, Corinne Cather, Meghan Shanahan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 30, 2021
Impairment in acquisition of conditioned fear in schizophreniaLauri Tuominen, Liana Romaniuk, Mohammed R Milad, et al.
Psychopharmacology|February 13, 2019
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trialXiaoduo Fan, Paul Copeland, Shukair Nawras, et al.
Biological Psychiatry|December 17, 2004
A failure of sleep-dependent procedural learning in chronic, medicated schizophreniaDara S Manoach, Matthew S Cain, Mark G Vangel, et al.
Journal of Abnormal Psychology|February 16, 2005
What is perseverated in schizophrenia? Evidence of abnormal response plasticity in the saccadic systemJason J S Barton, Mariya V Cherkasova, Kristen A Lindgren, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 24, 2016
Biomarkers for drug development in early psychosis: Current issues and promising directionsDonald C Goff, Klaus Romero, Jeffrey Paul, et al.
Journal of Dual Diagnosis|June 11, 2013
An Open Trial of Relapse Prevention Therapy for Smokers With SchizophreniaCorinne Cather, Michael A Dyer, Heather A Burrell, et al.
Pageof 21

Showing results (71-80 of 207) with videos related to

Sort By:
Pageof 21
Schizophrenia Research|September 1, 2023
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)Donald C Goff, Michele Santacatterina, Gillian Capichioni, et al.
Schizophrenia Bulletin|August 22, 2019
Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic TreatmentEsther M Blessing, Vishnu P Murty, Botao Zeng, et al.
The American Journal of Psychiatry|April 2, 2004
Anterior cingulate cortex activation during cognitive interference in schizophreniaStephan Heckers, Anthony P Weiss, Thilo Deckersbach, et al.
Schizophrenia Research|July 5, 2011
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophreniaJennifer D Gottlieb, Corinne Cather, Meghan Shanahan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 30, 2021
Impairment in acquisition of conditioned fear in schizophreniaLauri Tuominen, Liana Romaniuk, Mohammed R Milad, et al.
Psychopharmacology|February 13, 2019
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trialXiaoduo Fan, Paul Copeland, Shukair Nawras, et al.
Biological Psychiatry|December 17, 2004
A failure of sleep-dependent procedural learning in chronic, medicated schizophreniaDara S Manoach, Matthew S Cain, Mark G Vangel, et al.
Journal of Abnormal Psychology|February 16, 2005
What is perseverated in schizophrenia? Evidence of abnormal response plasticity in the saccadic systemJason J S Barton, Mariya V Cherkasova, Kristen A Lindgren, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 24, 2016
Biomarkers for drug development in early psychosis: Current issues and promising directionsDonald C Goff, Klaus Romero, Jeffrey Paul, et al.
Journal of Dual Diagnosis|June 11, 2013
An Open Trial of Relapse Prevention Therapy for Smokers With SchizophreniaCorinne Cather, Michael A Dyer, Heather A Burrell, et al.
Pageof 21